Tranexamic acid has become one of the most talked-about pigmentation ingredients of the last few years, and for once the hype has real research behind it. It’s especially interesting for melasma — the stubborn, relapse-prone patchy pigmentation that’s so common on Indian skin and so frustrating to treat. Here’s a clear look at what it is, what the studies show, and the safety points that genuinely matter.
What it is and how it works
Tranexamic acid (TXA) started life as a medicine to reduce bleeding — it’s antifibrinolytic, meaning it helps stabilise clots. Dermatologists noticed it also lightened pigmentation, and research has since shown it has anti-melanogenic effects: it calms the signalling between blood vessels, inflammation and pigment cells that drives melasma (Journal of Cosmetic Dermatology, 2025).
That mechanism is why TXA is a good fit for melasma specifically. Melasma isn’t only about melanin — it has a vascular and inflammatory side too — and TXA works on exactly that pathway, which most classic “brightening” ingredients don’t touch (European Medical Journal, 2024).
What the studies show
The evidence is genuinely encouraging, across forms:
- Topical TXA (commonly around 5%) meaningfully reduces melasma severity. In a 2025 randomised trial, a 5% topical cream lowered melasma severity scores by about 51% over 12 weeks (Journal of Cosmetic Dermatology, 2025).
- Oral TXA (typically 250 mg twice daily, prescription-only) performed similarly in the same trial — roughly a 59% reduction — with the difference between oral and topical not statistically significant. A broader review found oral TXA at 250–500 mg twice daily gave sustained improvement with generally mild side effects (review in PMC, 2025).
- Versus hydroquinone: topical and in-clinic TXA formulations have shown efficacy comparable to, or in some studies better than, hydroquinone — which is notable given hydroquinone’s stronger side-effect profile.
A fair caveat: most TXA trials are relatively small and single-centre, and there’s still no firm consensus on the ideal oral dose (Indian Journal of Dermatology, Venereology and Leprology, 2023). It’s promising and well-supported, not a miracle.
Topical or oral — which is right?
For most people starting out, topical is the sensible first step: the trial evidence shows it works, and it avoids the systemic considerations of the oral form. Because both worked similarly in head-to-head testing, the choice often comes down to preference, tolerability and a doctor’s guidance.
Oral TXA is a prescription medicine, and this is the important part. Because it affects clotting, it isn’t suitable for everyone — people with a history of blood clots, certain cardiovascular conditions, or clotting risk factors should not take it, and it must be prescribed and supervised by a doctor. Reported side effects are usually mild (some gastrointestinal upset, changes in menstrual flow), but the clotting consideration is not something to self-manage. Please don’t source oral tranexamic acid without a prescription.
Using topical TXA well
If you’re adding a topical TXA product:
- Pair it with daily sun protection. As with all pigmentation care, unprotected UV and visible light undo the work — this is the foundation, covered in our hyperpigmentation guide and UV and pigmentation.
- Give it 8–12 weeks. The trials ran over three months; pigment fades slowly, so consistency is everything.
- Introduce it gently. It’s generally well tolerated, but as with any active, start a few times a week and build up, especially if your barrier is sensitive.
- Manage expectations with melasma. TXA helps, but melasma relapses easily, particularly with sun and heat exposure — the Indian climate reality we discuss in why skincare has to be built for India. Ongoing maintenance and sun protection are part of the deal.
We’re formulating pH Matter’s pigmentation range with ingredients like this in mind, chosen for how they perform in Indian conditions. If you’d like a note when they’re ready, leave your email — no spam, just the science as it comes.
FAQ
Does tranexamic acid really work for pigmentation?
Yes, the evidence is encouraging, especially for melasma. Randomised trials show topical (≈5%) and oral (250 mg twice daily) forms both reduce melasma severity meaningfully over about 12 weeks, with results comparable to hydroquinone in some studies.
Is topical or oral tranexamic acid better?
In head-to-head trials they worked similarly, so topical is usually the sensible first step because it avoids the systemic considerations of the oral form. Oral TXA is prescription-only and chosen with a doctor.
Is oral tranexamic acid safe?
For suitable people under medical supervision, side effects are usually mild. But because it affects blood clotting, it’s not suitable for those with clotting risk or certain heart conditions, and must be prescribed by a doctor — never self-sourced.
How long does tranexamic acid take to work on melasma?
Typically 8–12 weeks of consistent use, in line with the trial durations. Pigment fades slowly, and melasma can relapse, so sun protection and maintenance matter.
Can I use tranexamic acid with vitamin C or niacinamide?
Generally yes — they work through different pathways and are often combined. Introduce actives one at a time, keep the barrier calm, and always pair with daily sun protection.
Written by the pH Matter Editorial team. Educational only, and not a substitute for a dermatologist’s or doctor’s advice. Oral tranexamic acid is a prescription medicine and should only be taken under medical supervision.